So anything that can help to regulate blood sugar and also lead to meaningful weight loss can truly help to protect these patients long-term from those conditions, Dr
Research Sources: New England Journal of Medicine: Tirzepatide as Compared with Semaglutide for the Treatment of Obesity. May 11, 2025
The primary factor is delayed gastric emptying and reduced gastrointestinal motility throughout the digestive tract
Then of course some may be metabolically healthy yet obese per BMI standards and some may be normal weight per BMI and yet metabolically obese and unhealthy
Watch for persistent headaches that dont respond well to hydration alone, muscle cramps or weakness, unusual fatigue or brain fog, heart palpitations, worsening nausea despite dose stability, dizziness when standing up, and constipation that doesnt improve with fiber intake